Volume 5, Number 6—December 1999
Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
|Erythromycin||No. of||No. with clindamycin MICs of|
aFour isolates characterized for ermAM and mefE; all four ermAM-/mefE+.
bSeven isolates characterized; all seven ermAM-/mefE+.
cThis isolate was ermAM+/mefE-.
dSeven isolates characterized; one ermAM-/mefE-; six ermAM-/mefE+.
eSeven isolates characterized; all seven ermAM-/mefE+
fFour isolates characterized; all four ermAM-/mefE+.
gThis isolate was ermAM-/mefE-.
hThree isolates characterized; all ermAM-/mefE+.
iThis isolate was ermAM+/mefE-.
jThis isolate was ermAM-/mefE+.
kThis isolate was ermAM-/mefE-.
lThirty-eight of these isolates were characterized; 26 were ermAM+/mefE-; 12 were ermAM+/mefE+.